Arvinas has joined Metastatic Breast Cancer Alliance as an Industry Member
Metastatic Breast Cancer Alliance shared a post on LinkedIn:
“ICYMI: Arvinas joined us as an industry member in 2024!
Committed to improving the lives of people with serious diseases including breast cancer, the company is progressing multiple investigational drugs through clinical development programs.”
Arvinas is a biopharmaceutical company focused on transforming the treatment of serious diseases, including breast cancer, through its pioneering PROTAC protein degrader platform.
This cutting-edge technology leverages the body’s natural protein disposal system to selectively target and degrade disease-causing proteins, offering a novel approach to drug development. Arvinas is advancing a robust pipeline of investigational drugs across multiple clinical development programs, with the aim of delivering more effective therapies for patients battling complex and hard-to-treat conditions.
With its innovative approach, Arvinas is dedicated to improving the lives of people affected by serious diseases and pushing the boundaries of targeted medicine.
The Metastatic Breast Cancer Alliance is a leading collective dedicated to improving the lives of individuals living with metastatic breast cancer (MBC).
Comprising cancer nonprofits, pharmaceutical and biotech industry members, and patient advocates, the Alliance serves as a powerful force for collaborative action. By uniting a dynamic group of trusted experts, the Alliance focuses on increasing awareness and education about MBC, advocating for policy changes, and pushing for more research funding.
Their efforts aim to extend and enhance life for those affected by metastatic breast cancer, with the ultimate goal of finding a cure and ending the disease. Through collective expertise and commitment, the Alliance is driving meaningful progress in the fight against MBC.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023